{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:29:05Z","timestamp":1785799745243,"version":"3.56.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,4,8]],"date-time":"2015-04-08T00:00:00Z","timestamp":1428451200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13045-015-0128-2","type":"journal-article","created":{"date-parts":[[2015,4,7]],"date-time":"2015-04-07T14:54:33Z","timestamp":1428418473000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Chromosomal rearrangement involving 11q23 locus in chronic myelogenous leukemia: a rare phenomenon frequently associated with disease progression and poor prognosis"],"prefix":"10.1186","volume":"8","author":[{"given":"Wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge E","family":"Cortes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C Cameron","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph D","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Bueso-Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,8]]},"reference":[{"issue":"4","key":"128_CR1","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1182\/blood-2012-03-380147","volume":"120","author":"R Hehlmann","year":"2012","unstructured":"Hehlmann R. How I, treat CML blast crisis. Blood. 2012;120(4):737\u201347. doi:10.1182\/blood-2012-03-380147.","journal-title":"Blood"},{"issue":"8","key":"128_CR2","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1182\/blood-2008-03-144790","volume":"113","author":"A Quintas-Cardama","year":"2009","unstructured":"Quintas-Cardama A, Cortes J. Molecular biology of bcr-abl1-positive chronic myeloid leukemia. Blood. 2009;113(8):1619\u201330. doi:10.1182\/blood-2008-03-144790.","journal-title":"Blood"},{"issue":"7","key":"128_CR3","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s00277-012-1421-6","volume":"91","author":"Q Mu","year":"2012","unstructured":"Mu Q, Ma Q, Wang Y, Chen Z, Tong X, Chen FF, et al. Cytogenetic profile of 1,863 Ph\/BCR-ABL-positive chronic myelogenous leukemia patients from the Chinese population. Ann Hematol. 2012;91(7):1065\u201372. doi:10.1007\/s00277-012-1421-6.","journal-title":"Ann Hematol"},{"issue":"3","key":"128_CR4","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/leu.2009.222","volume":"24","author":"C Haferlach","year":"2010","unstructured":"Haferlach C, Bacher U, Schnittger S, Weiss T, Kern W, Haferlach T. Similar patterns of chromosome abnormalities in CML occur in addition to the Philadelphia chromosome with or without tyrosine kinase inhibitor treatment. Leukemia. 2010;24(3):638\u201340. doi:10.1038\/leu.2009.222.","journal-title":"Leukemia"},{"key":"128_CR5","doi-asserted-by":"publisher","first-page":"582016","DOI":"10.1155\/2014\/582016","volume":"2014","author":"C Aydin","year":"2014","unstructured":"Aydin C, Cetin Z, Salim O, Yucel OK, Undar L, Berker KS. Previously unreported chromosomal aberrations of t(3;3)(q29;q23), t(4;11)(q21;q23), and t(11;18)(q10;q10) in a patient with accelerated phase Ph\u2009+\u2009CML. Case reports in genetics. 2014;2014:582016. doi:10.1155\/2014\/582016.","journal-title":"Case reports in genetics"},{"issue":"1","key":"128_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0165-4608(92)90061-C","volume":"63","author":"N Dastugue","year":"1992","unstructured":"Dastugue N, Duchayne E, Huguet F, Demur C, Plaisancie H, Calvas P, et al. t(9;11)(p22;q23) translocation in blastic phase of chronic myeloid leukemia. Cancer Genet Cytogenet. 1992;63(1):37\u201342.","journal-title":"Cancer Genet Cytogenet"},{"issue":"2","key":"128_CR7","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/0014-4800(90)90008-2","volume":"52","author":"O Haus","year":"1990","unstructured":"Haus O, Noworolska A, Laskowski M, Kuliszkiewicz-Janus M, Kozlowska J, Harlozinska-Szmyrka A, et al. Prognostic significance of secondary cytogenetic changes and nonspecific cross-reacting antigen (NCA) in patients with Ph-positive chronic myeloid leukemia. Exp Mol Pathol. 1990;52(2):235\u201342.","journal-title":"Exp Mol Pathol"},{"issue":"2","key":"128_CR8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0165-4608(93)90009-B","volume":"68","author":"L Li","year":"1993","unstructured":"Li L, Ritterbach J, Harbott J, Schroyens W, Lohmeyer J, Pralle H, et al. Blastic phase chronic myeloid leukemia with a four-break rearrangement: t(11;9)(9;22)(q23;p22q34;q11). Cancer Genet Cytogenet. 1993;68(2):131\u20134.","journal-title":"Cancer Genet Cytogenet"},{"issue":"1","key":"128_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S0165-4608(00)00382-4","volume":"126","author":"K Nishii","year":"2001","unstructured":"Nishii K, Usui E, Sakakura M, Miyata E, Ridge SA, Ford AM, et al. Additional t(11;17)(q23;q21) in a patient with Philadelphia-positive mixed lineage antigen-expressing leukemia. Cancer Genet Cytogenet. 2001;126(1):8\u201312.","journal-title":"Cancer Genet Cytogenet"},{"issue":"2","key":"128_CR10","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1600-0609.2007.00884.x","volume":"79","author":"L Otero","year":"2007","unstructured":"Otero L, Moellmann AC, Pombo-de-Oliveira MS, Ornellas MH, Pires V, Bouzas LF, et al. Additional t(1;11)(q21;q23) with mixed lineage leukemia rearrangement in T-blastic crisis of a Ph-positive chronic myeloid leukemia. Eur J Haematol. 2007;79(2):179\u201381. doi:10.1111\/j.1600-0609.2007.00884.x.","journal-title":"Eur J Haematol"},{"issue":"1","key":"128_CR11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0165-4608(99)00047-3","volume":"114","author":"E Rajcan-Separovic","year":"1999","unstructured":"Rajcan-Separovic E, Bence-Bruckler I, Wells P, Wang H. Fluorescence in situ hybridization analysis of complex translocations in two newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia patients. Cancer Genet Cytogenet. 1999;114(1):71\u20134.","journal-title":"Cancer Genet Cytogenet"},{"issue":"4","key":"128_CR12","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/sj.leu.2402877","volume":"17","author":"B Royer-Pokora","year":"2003","unstructured":"Royer-Pokora B, Hildebrandt B, Redmann A, Herold C, Kronenwett R, Haas R, et al. Simultaneous occurrence of a t(9;22) (Ph) with a t(2;11) in a patient with CML and emergence of a new clone with the t(2;11) alone after imatinib mesylate treatment. Leukemia. 2003;17(4):807\u201310. doi:10.1038\/sj.leu.2402877.","journal-title":"Leukemia"},{"issue":"2","key":"128_CR13","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.cancergencyto.2003.09.005","volume":"150","author":"K Suzuki","year":"2004","unstructured":"Suzuki K, Sugawara T, Kowata S, Utsugizawa T, Ito S, Murai K, et al. Uncommon karyotypic abnormality, t(11;19)(q23;p13.3), in a patient with blastic phase of chronic myeloid leukemia. Cancer Genet Cytogenet. 2004;150(2):159\u201363. doi:10.1016\/j.cancergencyto.2003.09.005.","journal-title":"Cancer Genet Cytogenet"},{"issue":"2","key":"128_CR14","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.4081\/hr.2011.e13","volume":"3","author":"A Zamecnikova","year":"2011","unstructured":"Zamecnikova A. Acquisition of mixed lineage leukemia rearrangement in a chronic myeloid leukemia patient while on imatinib. Hematology reports. 2011;3(2):e13.","journal-title":"Hematology reports"},{"issue":"26","key":"128_CR15","doi-asserted-by":"publisher","first-page":"6306","DOI":"10.1200\/JCO.2005.05.047","volume":"23","author":"SA Armstrong","year":"2005","unstructured":"Armstrong SA, Look AT. Molecular genetics of acute lymphoblastic leukemia. J Clin Oncol. 2005;23(26):6306\u201315. doi:10.1200\/JCO.2005.05.047.","journal-title":"J Clin Oncol"},{"issue":"11","key":"128_CR16","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1038\/sj.leu.2404903","volume":"21","author":"D Tomizawa","year":"2007","unstructured":"Tomizawa D, Koh K, Sato T, Kinukawa N, Morimoto A, Isoyama K, et al. Outcome of risk-based therapy for infant acute lymphoblastic leukemia with or without an MLL gene rearrangement, with emphasis on late effects: a final report of two consecutive studies, MLL96 and MLL98, of the Japan Infant Leukemia Study Group. Leukemia. 2007;21(11):2258\u201363. doi:10.1038\/sj.leu.2404903.","journal-title":"Leukemia"},{"issue":"7","key":"128_CR17","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1182\/blood-2003-02-0434","volume":"102","author":"C Schoch","year":"2003","unstructured":"Schoch C, Schnittger S, Klaus M, Kern W, Hiddemann W, Haferlach T. AML with 11q23\/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases. Blood. 2003;102(7):2395\u2013402. doi:10.1182\/blood-2003-02-0434.","journal-title":"Blood"},{"issue":"11","key":"128_CR18","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1038\/leu.2013.135","volume":"27","author":"C Meyer","year":"2013","unstructured":"Meyer C, Hofmann J, Burmeister T, Groger D, Park TS, Emerenciano M, et al. The MLL recombinome of acute leukemias in 2013. Leukemia. 2013;27(11):2165\u201376. doi:10.1038\/leu.2013.135.","journal-title":"Leukemia"},{"issue":"2","key":"128_CR19","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/sj.leu.2402804","volume":"17","author":"BB Zeisig","year":"2003","unstructured":"Zeisig BB, Schreiner S, Garcia-Cuellar MP, Slany RK. Transcriptional activation is a key function encoded by MLL fusion partners. Leukemia. 2003;17(2):359\u201365. doi:10.1038\/sj.leu.2402804.","journal-title":"Leukemia"},{"issue":"7","key":"128_CR20","doi-asserted-by":"publisher","first-page":"984","DOI":"10.3324\/haematol.2008.002436","volume":"94","author":"RK Slany","year":"2009","unstructured":"Slany RK. The molecular biology of mixed lineage leukemia. Haematologica. 2009;94(7):984\u201393. doi:10.3324\/haematol.2008.002436.","journal-title":"Haematologica"},{"issue":"24","key":"128_CR21","doi-asserted-by":"publisher","first-page":"10024","DOI":"10.1158\/0008-5472.CAN-08-2208","volume":"68","author":"DP Harper","year":"2008","unstructured":"Harper DP, Aplan PD. Chromosomal rearrangements leading to MLL gene fusions: clinical and biological aspects. Cancer Res. 2008;68(24):10024\u20137. doi:10.1158\/0008-5472.CAN-08-2208.","journal-title":"Cancer Res"},{"issue":"2","key":"128_CR22","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1182\/blood-2013-09-525741","volume":"124","author":"E Manara","year":"2014","unstructured":"Manara E, Baron E, Tregnago C, Aveic S, Bisio V, Bresolin S, et al. MLL-AF6 fusion oncogene sequesters AF6 into the nucleus to trigger RAS activation in myeloid leukemia. Blood. 2014;124(2):263\u201372. doi:10.1182\/blood-2013-09-525741.","journal-title":"Blood"},{"issue":"10","key":"128_CR23","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1200\/JCO.1998.16.10.3279","volume":"16","author":"J Cortes","year":"1998","unstructured":"Cortes J, Talpaz M, O\u2019Brien S, Rios MB, Majlis A, Keating M, et al. Suppression of cytogenetic clonal evolution with interferon alfa therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia. J Clin Oncol. 1998;16(10):3279\u201385.","journal-title":"J Clin Oncol"},{"issue":"10","key":"128_CR24","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.1182\/blood-2002-09-2790","volume":"101","author":"JE Cortes","year":"2003","unstructured":"Cortes JE, Talpaz M, Giles F, O\u2019Brien S, Rios MB, Shan J, et al. Prognostic significance of cytogenetic clonal evolution in patients with chronic myelogenous leukemia on imatinib mesylate therapy. Blood. 2003;101(10):3794\u2013800. doi:10.1182\/blood-2002-09-2790.","journal-title":"Blood"},{"issue":"5","key":"128_CR25","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1182\/blood-2002-03-0777","volume":"100","author":"ME O\u2019Dwyer","year":"2002","unstructured":"O\u2019Dwyer ME, Mauro MJ, Kurilik G, Mori M, Balleisen S, Olson S, et al. The impact of clonal evolution on response to imatinib mesylate (STI571) in accelerated phase CML. Blood. 2002;100(5):1628\u201333. doi:10.1182\/blood-2002-03-0777.","journal-title":"Blood"},{"issue":"11","key":"128_CR26","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1002\/cncr.25015","volume":"116","author":"D Verma","year":"2010","unstructured":"Verma D, Kantarjian H, Shan J, O\u2019Brien S, Estrov Z, Garcia-Manero G, et al. Survival outcomes for clonal evolution in chronic myeloid leukemia patients on second generation tyrosine kinase inhibitor therapy. Cancer. 2010;116(11):2673\u201381. doi:10.1002\/cncr.25015.","journal-title":"Cancer"},{"issue":"26","key":"128_CR27","doi-asserted-by":"publisher","first-page":"6760","DOI":"10.1182\/blood-2011-08-373902","volume":"118","author":"A Fabarius","year":"2011","unstructured":"Fabarius A, Leitner A, Hochhaus A, Muller MC, Hanfstein B, Haferlach C, et al. Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV. Blood. 2011;118(26):6760\u20138. doi:10.1182\/blood-2011-08-373902.","journal-title":"Blood"},{"issue":"6","key":"128_CR28","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1182\/blood-2013-05-501569","volume":"122","author":"M Baccarani","year":"2013","unstructured":"Baccarani M, Deininger MW, Rosti G, Hochhaus A, Soverini S, Apperley JF, et al. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013. Blood. 2013;122(6):872\u201384. doi:10.1182\/blood-2013-05-501569.","journal-title":"Blood"},{"issue":"10","key":"128_CR29","first-page":"1014","volume":"87","author":"E Giugliano","year":"2002","unstructured":"Giugliano E, Rege-Cambrin G, Scaravaglio P, Wlodarska I, Emanuel B, Stul M, et al. Two new translocations involving the 11q23 region map outside the MLL locus in myeloid leukemias. Haematologica. 2002;87(10):1014\u201320.","journal-title":"Haematologica"},{"issue":"2","key":"128_CR30","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1309\/RX27R8GJQM330C22","volume":"122","author":"MC Cox","year":"2004","unstructured":"Cox MC, Panetta P, Lo-Coco F, Del Poeta G, Venditti A, Maurillo L, et al. Chromosomal aberration of the 11q23 locus in acute leukemia and frequency of MLL gene translocation: results in 378 adult patients. Am J Clin Pathol. 2004;122(2):298\u2013306. doi:10.1309\/RX27-R8GJ-QM33-0C22.","journal-title":"Am J Clin Pathol"},{"issue":"20","key":"128_CR31","doi-asserted-by":"publisher","first-page":"5604","DOI":"10.1182\/blood-2011-04-348052","volume":"118","author":"SM Kornblau","year":"2011","unstructured":"Kornblau SM, Qiu YH, Zhang N, Singh N, Faderl S, Ferrajoli A, et al. Abnormal expression of FLI1 protein is an adverse prognostic factor in acute myeloid leukemia. Blood. 2011;118(20):5604\u201312. doi:10.1182\/blood-2011-04-348052.","journal-title":"Blood"},{"issue":"1","key":"128_CR32","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0888-7543(91)90124-W","volume":"11","author":"V Baud","year":"1991","unstructured":"Baud V, Lipinski M, Rassart E, Poliquin L, Bergeron D. The human homolog of the mouse common viral integration region, FLI1, maps to 11q23-q24. Genomics. 1991;11(1):223\u20134.","journal-title":"Genomics"},{"issue":"11","key":"128_CR33","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1080\/10428190410001723278","volume":"45","author":"M Loriaux","year":"2004","unstructured":"Loriaux M, Deininger M. Clonal cytogenetic abnormalities in Philadelphia chromosome negative cells in chronic myeloid leukemia patients treated with imatinib. Leuk Lymphoma. 2004;45(11):2197\u2013203. doi:10.1080\/10428190410001723278.","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"128_CR34","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1182\/blood-2007-01-070045","volume":"110","author":"E Jabbour","year":"2007","unstructured":"Jabbour E, Kantarjian HM, Abruzzo LV, O\u2019Brien S, Garcia-Manero G, Verstovsek S, et al. Chromosomal abnormalities in Philadelphia chromosome negative metaphases appearing during imatinib mesylate therapy in patients with newly diagnosed chronic myeloid leukemia in chronic phase. Blood. 2007;110(8):2991\u20135. doi:10.1182\/blood-2007-01-070045.","journal-title":"Blood"},{"issue":"8","key":"128_CR35","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1182\/blood-2006-04-017400","volume":"108","author":"C Kovitz","year":"2006","unstructured":"Kovitz C, Kantarjian H, Garcia-Manero G, Abruzzo LV, Cortes J. Myelodysplastic syndromes and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemia. Blood. 2006;108(8):2811\u20133. doi:10.1182\/blood-2006-04-017400.","journal-title":"Blood"},{"key":"128_CR36","unstructured":"Perel JM, McCarthy C, Walker O, Irving I, Williams B, Kennedy GA. Clinical significance of development of Philadelphia-chromosome negative clones in patients with chronic myeloid leukemia treated with imatinib mesylate. Haematologica. 2005;90 Suppl:ECR25."},{"issue":"3","key":"128_CR37","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/sj.leu.2403607","volume":"19","author":"U Bacher","year":"2005","unstructured":"Bacher U, Hochhaus A, Berger U, Hiddemann W, Hehlmann R, Haferlach T, et al. Clonal aberrations in Philadelphia chromosome negative hematopoiesis in patients with chronic myeloid leukemia treated with imatinib or interferon alpha. Leukemia. 2005;19(3):460\u20133. doi:10.1038\/sj.leu.2403607.","journal-title":"Leukemia"},{"issue":"7","key":"128_CR38","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/sj.leu.2402634","volume":"16","author":"MK Andersen","year":"2002","unstructured":"Andersen MK, Pedersen-Bjergaard J, Kjeldsen L, Dufva IH, Brondum-Nielsen K. Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8. Leukemia. 2002;16(7):1390\u20133. doi:10.1038\/sj.leu.2402634.","journal-title":"Leukemia"},{"issue":"3","key":"128_CR39","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/sj.leu.2402842","volume":"17","author":"YL Chee","year":"2003","unstructured":"Chee YL, Vickers MA, Stevenson D, Holyoake TL, Culligan DJ. Fatal myelodysplastic syndrome developing during therapy with imatinib mesylate and characterised by the emergence of complex Philadelphia negative clones. Leukemia. 2003;17(3):634\u20135. doi:10.1038\/sj.leu.2402842.","journal-title":"Leukemia"},{"issue":"11","key":"128_CR40","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1038\/sj.leu.2404865","volume":"21","author":"A Quintas-Cardama","year":"2007","unstructured":"Quintas-Cardama A, Kantarjian H, Abruzzo LV, Cortes J. Extramedullary BCR-ABL1-negative myeloid leukemia in a patient with chronic myeloid leukemia and synchronous cytogenetic abnormalities in Philadelphia-positive and -negative clones during imatinib therapy. Leukemia. 2007;21(11):2394\u20136. doi:10.1038\/sj.leu.2404865.","journal-title":"Leukemia"},{"issue":"7","key":"128_CR41","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1172\/JCI41246","volume":"120","author":"D Perrotti","year":"2010","unstructured":"Perrotti D, Jamieson C, Goldman J, Skorski T. Chronic myeloid leukemia: mechanisms of blastic transformation. J Clin Invest. 2010;120(7):2254\u201364. doi:10.1172\/JCI41246.","journal-title":"J Clin Invest"},{"issue":"4","key":"128_CR42","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000329389","volume":"126","author":"SG Lee","year":"2011","unstructured":"Lee SG, Park TS, Oh SH, Park JC, Yang YJ, Marschalek R, et al. De novo acute myeloid leukemia associated with t(11;17)(q23;q25) and MLL-SEPT9 rearrangement in an elderly patient: a case study and review of the literature. Acta Haematol. 2011;126(4):195\u20138. doi:10.1159\/000329389.","journal-title":"Acta Haematol"}],"container-title":["Journal of Hematology & Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-015-0128-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13045-015-0128-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-015-0128-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-015-0128-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T07:34:57Z","timestamp":1717832097000},"score":1,"resource":{"primary":{"URL":"https:\/\/jhoonline.biomedcentral.com\/articles\/10.1186\/s13045-015-0128-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,8]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["128"],"URL":"https:\/\/doi.org\/10.1186\/s13045-015-0128-2","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,8]]},"assertion":[{"value":"13 January 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"32"}}